Results 11 to 20 of about 110,265 (199)

Cost-effectiveness of Left Ventricular Assist Devices (LVADs) as destination therapy in the UK: An economic modelling study. [PDF]

open access: yesPLoS ONE
ObjectivesLeft Ventricular Assist Devices (LVADs) for destination therapy (DT) are used in many countries but in some, like the UK, LVADs are not commissioned due to uncertainty around their cost-effectiveness.
Tuba Saygın Avşar   +7 more
doaj   +2 more sources

Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom [PDF]

open access: yesESC Heart Failure, 2021
Aims Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation.
Stephan Schueler   +10 more
doaj   +2 more sources

Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries [PDF]

open access: yesLife
Heart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates.
David Dobarro   +33 more
doaj   +2 more sources

Destination Therapy with the magnetically levitated HVAD [PDF]

open access: yesJ Cardiothorac Surg, 2015
Destination therapy (DT) with mechanical circulatory support (MCS) for advanced-stage heart failure patients is an alternative therapy when there is no option of eventually providing the patient with heart transplantation. New generation magnetically levitated pumps encourage a broader use of DT.
Heim C   +6 more
europepmc   +3 more sources

Impact of mechanical circulatory support on donor heart allocation: past, present, and future [PDF]

open access: yesReviews in Cardiovascular Medicine, 2021
The United Network for Organ Sharing (UNOS) recently revised its heart allocation policy to address numerous shortcomings of the previous system. Implemented in 2018, the changes sought to reduce waiting list mortality, clearly define urgency status ...
Robert T. Tatum   +2 more
doaj   +1 more source

Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. [PDF]

open access: yesJAMA Intern Med, 2018
Allen LA   +15 more
europepmc   +3 more sources

Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Left ventricular assist devices (LVADs) improve outcomes in patients with end‐stage heart failure and are increasingly implanted for destination therapy.
Katherine C. Michelis   +8 more
doaj   +1 more source

Assessing Unmet Needs of Caregivers after Stroke: Occupational Therapist Practices and Perspectives [PDF]

open access: yes, 2020
Background: Family caregivers of stroke survivors often feel unprepared and overwhelmed post discharge with numerous unmet needs. Occupational therapists can play an integral role in addressing family caregivers’ needs.
Clymer, Deborah R   +2 more
core   +2 more sources

Implications of Transitional Care Interventions on Hospital Readmissions in Patients With Destination Therapy Left Ventricular Assist Devices [PDF]

open access: yes, 2019
Background: The rising number of patients with a left ventricular assist device (LVAD) require care management to successfully transition home after implantation. These patients and their families need to manage their heart failure, and the complexities
Hirschman, Karen   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy